Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Lantheus Holdings (LNTH)

Lantheus Holdings (LNTH)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 573,282
  • Shares Outstanding, K 39,756
  • Annual Sales, $ 347,340 K
  • Annual Income, $ 31,670 K
  • 60-Month Beta 1.26
  • Price/Sales 1.64
  • Price/Cash Flow 9.19
  • Price/Book 4.82

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/20
See More
  • Average Estimate 0.02
  • Number of Estimates 1
  • High Estimate 0.02
  • Low Estimate 0.02
  • Prior Year 0.27
  • Growth Rate Est. (year over year) -92.59%

Price Performance

See More
Period Period Low Period High Performance
1-Month
12.52 +15.18%
on 06/15/20
15.22 -5.26%
on 06/19/20
+0.30 (+2.12%)
since 06/10/20
3-Month
10.97 +31.51%
on 05/14/20
15.64 -7.80%
on 06/08/20
+1.21 (+9.16%)
since 04/09/20
52-Week
8.67 +66.32%
on 03/18/20
29.04 -50.34%
on 07/24/19
-13.70 (-48.72%)
since 07/10/19

Most Recent Stories

More News
Lantheus Holdings to Showcase the Potential of PyL(TM) Imaging Agent at the Virtual Society of Nuclear Medicine and Molecular Imaging (SNMMI) 2020 Annual Meeting

Lantheus Holdings, Inc. (the "Company") (NASDAQ: LNTH), the parent company of Lantheus Medical Imaging, Inc. and Progenics Pharmaceuticals, Inc., and a global leader in the development, manufacture and...

LNTH : 14.42 (+0.42%)
Lantheus Completes Merger with Progenics

Lantheus Holdings, Inc. (the "Company") (NASDAQ: LNTH), the parent company of Lantheus Medical Imaging, Inc. ("LMI"), a global leader in the development, manufacture and commercialization of innovative...

LNTH : 14.42 (+0.42%)
PGNX : 4.10 (-9.39%)
Independent Bank Group Set to Join S&P SmallCap 600

, /PRNewswire/ -- Independent Bank Group Inc. (NASD: IBTX) will replace Progenics Pharmaceuticals Inc. (NASD: PGNX) in the S&P SmallCap 600 effective prior to the opening of trading on . S&P Small-Cap...

IBTX : 38.89 (+5.16%)
PGNX : 4.10 (-9.39%)
LNTH : 14.42 (+0.42%)
SPGI : 351.81 (-0.26%)
Progenics Stockholders Approve Merger with Lantheus

Progenics Pharmaceuticals, Inc. (Nasdaq: PGNX) ("Progenics"), an oncology company developing innovative medicines and artificial intelligence to find, fight and follow cancer, announced that at a special...

LNTH : 14.42 (+0.42%)
PGNX : 4.10 (-9.39%)
Lantheus Stockholders Approve Share Issuance For Merger with Progenics

Lantheus Holdings, Inc. (NASDAQ: LNTH) ("Lantheus" or the "Company"), parent company of Lantheus Medical Imaging, Inc. ("LMI"), a leader in the development, manufacture and commercialization of innovative...

LNTH : 14.42 (+0.42%)
PGNX : 4.10 (-9.39%)
Lantheus Holdings to Present at the BMO 2020 Prescriptions for Success Virtual Healthcare Conference

Lantheus Holdings, Inc. (the "Company") (NASDAQ: LNTH), the parent company of Lantheus Medical Imaging, Inc. ("LMI"), a global leader in the development, manufacture and commercialization of innovative...

LNTH : 14.42 (+0.42%)
SHAREHOLDER ALERT: WeissLaw LLP Investigates Progenics Pharmaceuticals, Inc.

, /PRNewswire/ --  is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Progenics Pharmaceuticals, Inc. ("Progenics" or the "Company") (NASDAQ:...

PGNX : 4.10 (-9.39%)
LNTH : 14.42 (+0.42%)
Lantheus Holdings to Present at the Jefferies Virtual Healthcare Conference

Lantheus Holdings, Inc. (the "Company") (NASDAQ: LNTH), the parent company of Lantheus Medical Imaging, Inc. ("LMI"), a global leader in the development, manufacture and commercialization of innovative...

LNTH : 14.42 (+0.42%)
Exciting Diagnostic Innovations Alter the Healthcare Landscape

, /PRNewswire/ -- Among the plethora of segments within the medical devices industry, the medical imaging technology segment is one of the most vibrant. It includes various technologies such as x-ray...

GE : 6.69 (+1.67%)
IZOZF : 0.1768 (+7.15%)
IZO.CN : 0.235 (+2.17%)
LNTH : 14.42 (+0.42%)
RDNT : 15.55 (+3.94%)
VREX : 14.98 (+2.53%)
Progenics Class Action: Halper Sadeh LLP Announces Filing Of Shareholder Class Action Lawsuit Against Progenics Pharmaceuticals, Inc.; Investors Are Encouraged To Contact The Firm

, /PRNewswire/ -- Halper Sadeh LLP, a global investor rights law firm, announces the filing of a shareholder class action lawsuit against Progenics Pharmaceuticals, Inc. (NASDAQ: PGNX) in connection...

LNTH : 14.42 (+0.42%)
PGNX : 4.10 (-9.39%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Buy with a Weakening short term outlook on maintaining the current direction.

See More Share

Trade LNTH with:

Business Summary

Lantheus Holdings, Inc. is involved in developing, manufacturing, selling and distributing diagnostic medical imaging agents and products for diagnosis of cardiovascular and other diseases. It serves to hospitals, clinics, group practices, integrated delivery networks, group purchasing organizations,...

See More

Key Turning Points

2nd Resistance Point 14.77
1st Resistance Point 14.59
Last Price 14.42
1st Support Level 14.11
2nd Support Level 13.81

See More

52-Week High 29.04
Fibonacci 61.8% 21.26
Fibonacci 50% 18.85
Fibonacci 38.2% 16.45
Last Price 14.42
52-Week Low 8.67

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar